Compound
D1333 | SB202190
| Toxicity | Dose | Time | Species | Model | Method | Action | Positive criterion | Reference |
|---|---|---|---|---|---|---|---|---|
| TRANSPORT OF CALCIUM | 10 μM | intact and in permeabilized HeLa cells (MM5 cells expressing mitmutAEQ ) | mitochondrial Ca2+ uptake | increase | 233 | |||
| Target | Dose | Time | Species | Model | Method | Action | Positive criterion | Reference |
|---|---|---|---|---|---|---|---|---|
| mCU (mitochondrial calcium uniporter) | 10 μM | intact and in permeabilized HeLa cells (MM5 cells expressing mitmutAEQ ) | mitochondrial Ca2+ uptake | activate | 233 | |||
| Pictogram | Signal | Statements | Precautionary Statement Codes |
|---|---|---|---|
 |
Warning |
Aggregated GHS information provided by 38 companies from 1 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies. H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation] H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation] H335 (100%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure Respiratory tract irritation] Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. |
P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, and P501; (The corresponding statement to each P-code can be found at the GHS Classification page.) |
| 121S307 | 152121-30-7 | 2RE |
| 4-(4-(4-fluorophenyl)-5-(pyridin-4-yl)-1H-imidazol-2-yl)phenol | 4-(4-(4-fluorophenyl)-5-(pyridin-4-yl)-2H-imidazol | 4-(4-Fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)-1H-imidazole |
| 4-(4-Fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)1H-imidazole | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole | 4-(5-(4-fluorophenyl)-4-(pyridin-4-yl)-1H-imidazol-2-yl)phenol |
| 4-[4-(4-Fluoro-phenyl)-5-pyridin-4-yl-1H-imidazol-2-yl]-phenol | 4-[4-(4-Fluorophenyl)-5-(4-pyridinyl)-1H-imidazol-2-yl]phenol | 4-[4-(4-Fluorphenyl)-5-(4-pyridinyl)-1H-imidazol-2-yl]phenol |
| 4-[4-(4-fluorophenyl)-5-(4-pyridyl)-1H-imidazol-2-yl]phenol | 4-[4-(4-fluorophenyl)-5-(4-pyridyl)-4-imidazolin-2-ylidene]cyclohexa-2,5-dien-1-one | 4-[4-(4-fluorophenyl)-5-(pyridin-4-yl)-1H-imidazol-2-yl]phenol |
| 4-[4-(4-fluorophenyl)-5-pyridin-4-yl-1,3-dihydroimidazol-2-ylidene]-1-cyclohexa-2,5-dienone | 4-[4-(4-fluorophenyl)-5-pyridin-4-yl-1,3-dihydroimidazol-2-ylidene]cyclohexa-2,5-dien-1-one | 4-[5-(4-fluorophenyl)-4-(pyridin-4-yl)-1H-imidazol-2-yl]phenol |
| 4o77 | ABP000229 | ACN-053035 |
| AK-51368 | AKOS005146403 | AKOS026750414 |
| AOB2557 | AS-16228 | BCP00675 |
| BDBM13531 | BDBM50044784 | BMK1-F3 |
| BRD-K54330070-001-05-5 | BRD-K54330070-001-07-1 | BS0317 |
| BSPBio_001106 | Bio1_000479 | Bio1_000968 |
| Bio1_001457 | Bio2_000393 | Bio2_000873 |
| BiomolKI2_000057 | BiomolKI_000051 | C20H14FN3O |
| CCG-100655 | CCG-204268 | CHEBI:79090 |
| CHEBI:92952 | CHEMBL278041 | CS-0141 |
| DTXSID7041120 | EC-000.2317 | EU-0100173 |
| EX-A313 | FHPI | FHPI|||4-(4-(4-Fluorophenyl)-5-(pyridin-4-yl)-1H-imidazol-2-yl)phenol |
| FT-0743934 | GK2422 | GTPL4307 |
| HMS1362H07 | HMS1792H07 | HMS1990H07 |
| HMS2235B15 | HMS3229M22 | HMS3244I13 |
| HMS3244I14 | HMS3244J13 | HMS3260D07 |
| HMS3267J19 | HMS3371G22 | HMS3403H07 |
| HMS3412C22 | HMS3654O15 | HMS3674G07 |
| HMS3676C22 | HY-10295 | IDI1_002148 |
| InSolution&trade | J-513574 | J-690315 |
| KBio2_000446 | KBio2_003014 | KBio2_005582 |
| KBio3_000831 | KBio3_000832 | KBioGR_000446 |
| KBioSS_000446 | Kinome_3708 | LP00173 |
| LS-186973 | LS-187615 | Lopac-S-7067 |
| Lopac0_000173 | MFCD00941964 | MLS002153419 |
| MLS006010258 | NCGC00015962-01 | NCGC00015962-02 |
| NCGC00015962-03 | NCGC00015962-04 | NCGC00015962-05 |
| NCGC00015962-06 | NCGC00015962-07 | NCGC00015962-08 |
| NCGC00015962-09 | NCGC00015962-10 | NCGC00025089-01 |
| NCGC00025089-02 | NCGC00025089-03 | NCGC00025089-04 |
| NCGC00025089-05 | NCGC00025089-06 | NCGC00260858-01 |
| PVX798P8GI | Phenol, 4-[4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazol-2-yl]- | Q27088696 |
| Q27164687 | QC-9800 | S 7067 |
| SB 202190 | SB 202190 | SB 202190, >=98% (HPLC) |
| SB 202190, Immobilized | SB 202190/SB-202190 | SB-202190 |
| SB202190 | SB202190 (FHPI) | SC-27980 |
| SCHEMBL1230814 | SCHEMBL158854 | SDCCGSBI-0050161.P003 |
| SMP2_000191 | SMR001230795 | SR-01000075720 |
| SR-01000075720-1 | SR-01000597393 | SR-01000597393-1 |
| SW218110-2 | SYN1073 | Tocris-1264 |
| Tox21_500173 | UNII-PVX798P8GI | X7402 |
| ZINC14951176 | ZINC89221712 | ZX-AFC001670 |
| biotinylated SB202190 | cc-468 | s1077 |
| CAS Number | 152121-30-7 |
| PubChem Compound | 5169 |